Article
An early-onset specific polygenic risk score optimizes age-based risk estimate and stratification of prostate cancer: population-based cohort study.
Journal of translational medicine - 17 Apr 2024
Cheng Yifei, Wu Lang, Xin Junyi, Ben Shuai, Chen Silu, Li Huiqin, Zhao Lingyan, Wang Meilin, Cheng Gong, Du Mulong
Abstract excerpt
BACKGROUND: Early-onset prostate cancer (EOPC, ≤ 55 years) has a unique clinical entity harboring high genetic risk, but the majority of EOPC patients still substantial opportunity to be early-detected thus suffering an unfavorable prognosis. A refined understanding of age-based polygenic risk score (PRS) for prostate cancer (PCa) would be essential for personalized risk stratification. METHODS: We included...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
